FY2025 · ended Dec 31, 2025 · Revenue $197.14M, +34.3% YoY · Filed Mar 3, 2026
Strata Critical Medical, Inc. (SRTA) files with the SEC under industry code 4700, Transportation Services. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $197.1 million and net income of $41.3 million. Free cash flow was -$58.5 million. As of Sep 30, 2026 it held $41.6 million in cash and investments and $3.6 million in total debt.
Revenue (TTM)
$280.76M
+68.4% vs year-ago TTM
Net income (TTM)
$-24.81M
-161.4% vs year-ago TTM
Operating cash flow (TTM)
$10.72M
+125.3% vs year-ago TTM
Free cash flow (TTM)
$806,000
+101.5% vs year-ago TTM
EPS (TTM)
$-0.29
-157.5% vs year-ago TTM
Dividend per share
None
Shares outstanding
86.99M
+9.2% vs prior year
Net cash
$38.02M
as of Sep 30, 2026
Operating margin
-6.6%
FY 2026
Company profile
- Industry
- Transportation Services (SIC 4700)
- Listed as
- SRTA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Accelerated filer
- SEC CIK
- 1779128
- Former names
- Blade Air Mobility, Inc. (until Aug 18, 2025); Experience Investment Corp. (until May 7, 2021)
Other Transportation Services companies
- Booking Holdings Inc. BKNG
- Expedia Group, Inc. EXPE
- XPO, Inc. XPO
- Gatx Corp GATX
- GXO Logistics, Inc. GXO
- Hafnia Ltd HAFN
- RXO, Inc. RXO
- MakeMyTrip Ltd MMYT
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Sep 30, 2021 |
|---|---|---|---|---|---|
| Revenue | $197.1M | $146.8M | $225.2M | $146.1M | $50.5M |
| Operating income | -$22.4M | -$22.5M | -$68.1M | -$53.5M | -$24.1M |
| Net income | $41.3M | -$27.3M | -$56.1M | -$27.3M | -$40.1M |
| Diluted EPS | $0.50 | -$0.35 | -$0.76 | -$0.38 | -$0.93 |
| Operating cash flow | -$48.9M | -$2.5M | -$32.3M | -$37.1M | -$15.6M |
| Free cash flow | -$58.5M | -$33.4M | -$34.5M | -$37.9M | -$15.9M |
| Total assets | $325.5M | $256.7M | $294.9M | $325.0M | $343.4M |
| Total liabilities | $46.4M | $34.7M | $60.6M | $50.5M | $52.2M |
| Stockholders' equity | $279.1M | $221.9M | $234.3M | $274.5M | $291.2M |
| Cash and investments | $61.2M | $127.1M | $166.1M | $192.1M | $304.1M |
| Total debt | $3.3M | $9.3M | $24.5M | $18.3M | $653,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2026 | May 28, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
All 574 Strata Critical Medical, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.